Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of Pioglitazone-Azilsartan in Type 2 Diabetes
NCT01124656Phase 3Terminated
- Sponsor
- Takeda
- Start
- Sep 2006
- Primary completion
- May 2007
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of azilsartan, pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Sep 2006; status: terminated.
02
Drugs
azilsartanpioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01124656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01124656.